Home / Stocks / GENB

GENB insider trading

Generate Biomedicines, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$150.3M
Buys · last 90 days
0 · $0
Most recent buy
2026-03-06

Cluster buy detected

5 insiders bought GENB within a short window (2026-03-02→2026-03-04), $150.3M in total — cluster score 70/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-06Nally Michaelcluster
Chief Executive Officer
Bought20,000$12.00$240k
2026-03-02Grous Bethcluster
Chief People Officer
Bought300$16.00$5k
2026-03-02Silvers Jasoncluster
President & CFO
Bought2,000$16.00$32k
2026-03-02AFEYAN NOUBARcluster
Director · 10% owner
Bought4,687,500$16.00$75.0M
2026-03-02Mendillo Jane Lcluster
Director
Bought1,500$16.00$24k
2026-03-02AFEYAN NOUBARcluster
Director · 10% owner
Bought4,687,500$16.00$75.0M

Most active insider buyers

InsiderRoleBuysTotal bought
AFEYAN NOUBARDirector · 10% owner2$150.0M
Nally MichaelChief Executive Officer1$240k
Silvers JasonPresident & CFO1$32k
Mendillo Jane LDirector1$24k
Grous BethChief People Officer1$5k

See GENB on the chart

Every insider buy and sell for GENB plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.